PortfoliosLab logoPortfoliosLab logo
JSPR vs. IAG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JSPR vs. IAG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and IAMGOLD Corporation (IAG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JSPR achieves a -73.70% return, which is significantly lower than IAG's 4.24% return.


JSPR

1D
-9.58%
1M
-50.19%
YTD
-73.70%
6M
-74.12%
1Y
-91.98%
3Y*
-68.77%
5Y*
10Y*

IAG

1D
2.14%
1M
5.40%
YTD
4.24%
6M
13.39%
1Y
131.36%
3Y*
80.36%
5Y*
35.96%
10Y*
16.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JSPR vs. IAG - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JSPR
Jasper Therapeutics, Inc.
-73.70%-91.44%170.98%63.39%-93.85%-48.08%
IAG
IAMGOLD Corporation
4.24%219.57%103.95%-1.94%-17.57%42.27%

Correlation

The correlation between JSPR and IAG is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Sep 27, 2021

0.09

Fundamentals

Market Cap

JSPR:

$13.80M

IAG:

$10.21B

EPS

JSPR:

-$2.87

IAG:

$1.73

PB Ratio

JSPR:

4.06

IAG:

2.36

Total Revenue (TTM)

JSPR:

$0.00

IAG:

$3.42B

Gross Profit (TTM)

JSPR:

-$290.00K

IAG:

$1.64B

EBITDA (TTM)

JSPR:

-$72.26M

IAG:

$1.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JSPR vs. IAG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR
JSPR Risk / Return Rank: 55
Overall Rank
JSPR Sharpe Ratio Rank: 77
Sharpe Ratio Rank
JSPR Sortino Ratio Rank: 22
Sortino Ratio Rank
JSPR Omega Ratio Rank: 22
Omega Ratio Rank
JSPR Calmar Ratio Rank: 22
Calmar Ratio Rank
JSPR Martin Ratio Rank: 1111
Martin Ratio Rank

IAG
IAG Risk / Return Rank: 8686
Overall Rank
IAG Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
IAG Sortino Ratio Rank: 8383
Sortino Ratio Rank
IAG Omega Ratio Rank: 8383
Omega Ratio Rank
IAG Calmar Ratio Rank: 8787
Calmar Ratio Rank
IAG Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. IAG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and IAMGOLD Corporation (IAG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JSPRIAGDifference
Sharpe ratioReturn per unit of total volatility

-3.06

Sortino ratioReturn per unit of downside risk

-4.65

Omega ratioGain probability vs. loss probability

0.70

1.34

-0.64

Calmar ratioReturn relative to maximum drawdown

-0.99

3.82

-4.81

Martin ratioReturn relative to average drawdown

-1.30

8.90

-10.20

JSPR vs. IAG - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.88, which is lower than the IAG Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of JSPR and IAG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JSPRIAGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.88

2.18

-3.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.29

0.11

-0.40

Drawdowns

JSPR vs. IAG - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.71%, roughly equal to the maximum IAG drawdown of -95.55%. Use the drawdown chart below to compare losses from any high point for JSPR and IAG.


Loading charts...

Drawdown Indicators


JSPRIAGDifference

Max Drawdown

Largest peak-to-trough decline

-99.71%

-95.55%

-4.16%

Max Drawdown (1Y)

Largest decline over 1 year

-92.94%

-34.60%

-58.34%

Max Drawdown (3Y)

Largest decline over 3 years

-98.40%

-34.60%

-63.80%

Max Drawdown (5Y)

Largest decline over 5 years

-74.25%

Max Drawdown (10Y)

Largest decline over 10 years

-86.46%

Current Drawdown

Current decline from peak

-99.71%

-30.04%

-69.67%

Average Drawdown

Average peak-to-trough decline

-88.46%

-56.21%

-32.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

70.70%

14.82%

+55.88%

Volatility

JSPR vs. IAG - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 47.65% compared to IAMGOLD Corporation (IAG) at 19.74%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than IAG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JSPRIAGDifference

Volatility (1M)

Calculated over the trailing 1-month period

47.65%

19.74%

+27.91%

Volatility (6M)

Calculated over the trailing 6-month period

77.38%

47.11%

+30.27%

Volatility (1Y)

Calculated over the trailing 1-year period

105.09%

60.52%

+44.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

242.64%

60.25%

+182.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

242.64%

58.51%

+184.13%

Dividends

JSPR vs. IAG - Dividend Comparison

Neither JSPR nor IAG has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

JSPR vs. IAG - Financials Comparison

This section allows you to compare key financial metrics between Jasper Therapeutics, Inc. and IAMGOLD Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B202220232024202520260
1.03B
(JSPR) Total Revenue
(IAG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JSPR and IAG have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JSPR has higher volatility (47.65%) compared to IAG (19.74%). In terms of maximum drawdown, JSPR dropped -99.71% vs IAG's -95.55%.

IAG currently has the higher Sharpe Ratio (2.18 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JSPR and IAG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer